https://www.mskcc.org/news-releases/asco-2023-new-research-from-mskcc-identifies-significant-treatment-advancement-for-brain-tumors
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center Identifies Significant...
Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with...
sloan kettering cancer centerasco 2023new research